NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Aurinia Pharmaceuticals (AUPH)

Technical Analysis Report for NASDAQ stock AUPH Aurinia Pharmaceuticals. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals then click here. or read Experts views on Aurinia Pharmaceuticals or Forecast & share price targets of Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Opened at 14.32 and Closed at: 14.21, which is 0.28% of previous session's close. It moved within a range of 14.03 and 14.51
The session was a Bearish session with an average volume of 1342100, which is -36.03% of previous session's volumes.

• Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
• Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
• The stock has shown an up move, and its long term trend is also positive and in an uptrend.

Support for tomorrow is 13.88 and resistance for tomorrow is 14.36
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 13.99, 13.77 resistance for tomorrow's hourly charts is 14.47, 14.73

10 Day SMA for Aurinia Pharmaceuticals (AUPH) is 14.36 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Aurinia Pharmaceuticals (AUPH) is 14.42 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Aurinia Pharmaceuticals (AUPH) is 14.97 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 14.54 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Aurinia Pharmaceuticals is 12.31 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Aurinia Pharmaceuticals is at 14.42 and 200 DMA is at 12.31, while 50 DMA and 100 DMA are at 14.97 and 14.54 respectively

Aurinia Pharmaceuticals (AUPH) moving average of 20 SMA is at 14.42 and 20 EMA is at 14.45

Aurinia Pharmaceuticals (AUPH) moving average of 50 SMA is at 14.97 and 50 EMA is at 14.66

Aurinia Pharmaceuticals (AUPH) moving average of 100 SMA is at 14.54 and 100 EMA is at 14.18

Aurinia Pharmaceuticals (AUPH) moving average of 200 SMA is at 12.31 and 200 EMA is at 12.82

Aurinia Pharmaceuticals has performed better than Trupanion Inc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Tandem Diabetes has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Tandem Diabetes, about 36.35% more returns!

Tg Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Tg Therapeutics, about 5.46% more returns!

Aurinia Pharmaceuticals has performed better than Soleno Therapeutics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Si Bone has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 3.13% more returns!

Rigel Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 2.21% more returns!

Aurinia Pharmaceuticals has performed better than Ultragenyx Pharmaceutical in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Pacira Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 7.81% more returns!

Aurinia Pharmaceuticals has performed better than Mesoblast in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Agios Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 11.12% more returns!

Aurinia Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Biolife Solutions has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Biolife Solutions, about 5.17% more returns!

Capricor Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 14.53% more returns!

Aurinia Pharmaceuticals has performed better than Collegium Pharmaceutical in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Catalyst Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Catalyst Pharmaceuticals, about 1.29% more returns!

Denali Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Denali Therapeutics, about 2.99% more returns!

Enanta Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 13.5% more returns!

Galapagos Nv has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Galapagos Nv, about 5.1% more returns!

Aurinia Pharmaceuticals has performed better than Icon Plc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Aurinia Pharmaceuticals Technical analysis of indicators

Price action analysis of Aurinia Pharmaceuticals (AUPH) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Aurinia Pharmaceuticals in short term and the sell signal is strong.

Aurinia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Aurinia Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 14.33 and Aurinia Pharmaceuticals AUPH stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Aurinia Pharmaceuticals AUPH stock. Volume based technical analysis of Aurinia Pharmaceuticals AUPH stock is negative.

Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AUPH Experts View which covers a lot of information including buying and selling signals

AUPH future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Aurinia Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet